Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC)

被引：0
|
作者：
O'Reilly, E. M.
Jarnagin, W. R.
Brennan, M. F.
Winston, C.
Tang, L. H.
Capanu, M.
Schattner, M.
Chen, L. Y.
DeMatteo, R. P.
DiMaio, C. J.
D'Angelica, M. I.
Kurtz, R. C.
Klimstra, D. S.
Lowery, M. A.
Coit, D. G.
Reidy, D. L.
Allen, P. J.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.4065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4065
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma - Final results of a single-institution phase II study
    Porta, C
    Zimatore, M
    Imarisio, I
    Natalizi, A
    Sartore-Bianchi, A
    Danova, M
    Riccardi, A
    CANCER, 2004, 100 (10) : 2132 - 2138
  • [22] Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
    Marron, Thomas U.
    Fiel, Maria Isabel
    Hamon, Pauline
    Fiaschi, Nathalie
    Kim, Edward
    Ward, Stephen C.
    Zhao, Zhen
    Kim, Joel
    Kennedy, Paul
    Gunasekaran, Ganesh
    Tabrizian, Parissa
    Doroshow, Deborah
    Legg, Meredith
    Hammad, Ashley
    Magen, Assaf
    Kamphorst, Alice O.
    Shareef, Muhammed
    Gupta, Namita T.
    Deering, Raquel
    Wang, Wei
    Wang, Fang
    Thanigaimani, Pradeep
    Mani, Jayakumar
    Troncoso, Leanna
    Tabachnikova, Alexandra
    Chang, Christie
    Akturk, Guray
    Buckup, Mark
    Hamel, Steven
    Ioannou, Giorgio
    Hennequin, Clotilde
    Jamal, Hajra
    Brown, Haley
    Bonaccorso, Antoinette
    Labow, Daniel
    Sarpel, Umut
    Rosenbloom, Talia
    Sung, Max W.
    Kou, Baijun
    Li, Siyu
    Jankovic, Vladimir
    James, Nicola
    Ham, Sara C.
    Cheung, Hung Kam
    Sims, Jennifer S.
    Miller, Elizabeth
    Bhardwaj, Nina
    Thurston, Gavin
    Lowy, Israel
    Gnjatic, Sacha
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (03): : 219 - 229
  • [23] Gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer: A multicenter, single-arm, phase I/II trial
    Pressiani, T.
    Balsano, R.
    Giordano, L.
    Milella, M.
    Bergamo, F.
    Bozzarelli, S.
    Noventa, S.
    Ferrari, D.
    Scartozzi, M.
    Parra, H. J. Soto
    Auriemma, A.
    Solda, C.
    Zaniboni, A.
    Zecchetto, C.
    Rizzato, M. D.
    Rimassa, L.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S120 - S120
  • [24] NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
    Shishir K. Maithel
    Jessica M. Keilson
    Hop S. Tran Cao
    Manali Rupji
    Amit Mahipal
    Bruce S. Lin
    Milind M. Javle
    Sean P. Cleary
    Mehmet Akce
    Jeffrey M. Switchenko
    Flavio G. Rocha
    Annals of Surgical Oncology, 2023, 30 : 6558 - 6566
  • [25] Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial.
    Funt, Samuel Aaron
    Lattanzi, Michael
    Whiting, Karissa
    Al-Ahmadie, Hikmat A.
    Quinlan, Colleen
    Teo, Min Yuen
    Kamradt, Jeffrey
    Khalil, Maged F.
    Ostrovnaya, Irina
    Mccoy, Asia S.
    Hettich, Grace
    Jihad, Marwah
    Folefac, Edmund
    Huang, William C.
    Bajorin, Dean F.
    Iyer, Gopa
    Bochner, Bernard H.
    Balar, Arjun Vasant
    Mortazavi, Amir
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study
    Viviana Vitolo
    Lorenzo Cobianchi
    Silvia Brugnatelli
    Amelia Barcellini
    Andrea Peloso
    Angelica Facoetti
    Alessandro Vanoli
    Sara Delfanti
    Lorenzo Preda
    Silvia Molinelli
    Catherine Klersy
    Piero Fossati
    Roberto Orecchia
    Francesca Valvo
    BMC Cancer, 19
  • [27] Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study
    Vitolo, Viviana
    Cobianchi, Lorenzo
    Brugnatelli, Silvia
    Barcellini, Amelia
    Peloso, Andrea
    Facoetti, Angelica
    Vanoli, Alessandro
    Delfanti, Sara
    Preda, Lorenzo
    Molinelli, Silvia
    Klersy, Catherine
    Fossati, Piero
    Orecchia, Roberto
    Valvo, Francesca
    BMC CANCER, 2019, 19 (01)
  • [28] Neoadjuvant therapy of camrelizumab combined with chemotherapy in patients (pts) with resectable esophageal squamous cell cancer (ESCC): A single-center, single-arm, exploratory clinical trial
    Yang, Ji Chen
    Jiao, Wenjie
    Hua, Feng
    Zhao, Xiaoming
    Yang, Wenfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    O'Reilly, Eileen Mary
    Lowery, Maeve Aine
    Yu, Kenneth H.
    Capanu, Marinela
    Stadler, Zsofia Kinga
    Epstein, Andrew S.
    Golan, Talia
    Segal, Amiel
    Segal, Michal
    Salo-Mullen, Erin E.
    Tang, Laura H.
    Hollywood, Ellen
    Moynahan, Mary Ellen
    Do, Kinh G.
    Moore, Malcolm J.
    Kindler, Hedy Lee
    Mayer, Robert J.
    Chen, Alice P.
    Kelsen, David Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial
    Tang, Zhaoqing
    Wang, Yan
    Yu, Yiyi
    Cui, Yuehong
    Liang, Liang
    Xu, Chen
    Shen, Zhenbin
    Shen, Kuntang
    Wang, Xuefei
    Liu, Tianshu
    Sun, Yihong
    BMC MEDICINE, 2022, 20 (01)
12345